SG11201510802QA - Combination therapy for prostate cancer using botanical compositions and docetaxel - Google Patents

Combination therapy for prostate cancer using botanical compositions and docetaxel

Info

Publication number
SG11201510802QA
SG11201510802QA SG11201510802QA SG11201510802QA SG11201510802QA SG 11201510802Q A SG11201510802Q A SG 11201510802QA SG 11201510802Q A SG11201510802Q A SG 11201510802QA SG 11201510802Q A SG11201510802Q A SG 11201510802QA SG 11201510802Q A SG11201510802Q A SG 11201510802QA
Authority
SG
Singapore
Prior art keywords
docetaxel
prostate cancer
combination therapy
botanical compositions
botanical
Prior art date
Application number
SG11201510802QA
Other languages
English (en)
Inventor
James Dao
Jeffery Dao
William Gerwick
Lena Gerwick
Maryann Jordan
Leslie Wilson
Original Assignee
Genyous Biomed Internat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genyous Biomed Internat filed Critical Genyous Biomed Internat
Publication of SG11201510802QA publication Critical patent/SG11201510802QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
SG11201510802QA 2013-06-03 2014-06-03 Combination therapy for prostate cancer using botanical compositions and docetaxel SG11201510802QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361830626P 2013-06-03 2013-06-03
PCT/US2014/040769 WO2014197519A1 (en) 2013-06-03 2014-06-03 Combination therapy for prostate cancer using botanical compositions and docetaxel

Publications (1)

Publication Number Publication Date
SG11201510802QA true SG11201510802QA (en) 2016-02-26

Family

ID=52008544

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201510802QA SG11201510802QA (en) 2013-06-03 2014-06-03 Combination therapy for prostate cancer using botanical compositions and docetaxel

Country Status (7)

Country Link
US (1) US20160143971A1 (ja)
EP (1) EP3003490B1 (ja)
JP (1) JP2016523849A (ja)
CN (1) CN105636647A (ja)
CA (1) CA2951110A1 (ja)
SG (1) SG11201510802QA (ja)
WO (1) WO2014197519A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018217237A1 (en) * 2017-05-26 2018-11-29 Genyous Biomed International Combination therapy for cancer using botanical compositions and enzalutamide
US10835538B2 (en) * 2018-03-28 2020-11-17 Nymox Corporation Method of treating benign prostatic hyperlasia with antibiotics
CN108836994B (zh) * 2018-07-25 2021-06-18 南京林业大学 一种人工林树皮皂苷类活性成分的提取方法
CN117064899B (zh) * 2023-10-13 2024-01-23 暨南大学附属第一医院（广州华侨医院） 灵芝酸a在制备治疗去势抵抗性前列腺癌的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395770B1 (en) * 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US5910308A (en) 1997-03-19 1999-06-08 Sante International Inc. Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis
US6168795B1 (en) 1998-06-09 2001-01-02 Sant{acute over (e)} International Inc. Method for anticancer therapy using an herbal extract composition
WO2005044182A2 (en) * 2003-09-08 2005-05-19 Genyous Biomed International Inc. Compositions of botanical extracts for cancer therapy
WO2005029963A1 (en) * 2003-09-22 2005-04-07 Genyous Biomed International Inc. Hippophae rhamnoides compositions for cancer therapy
US20050196409A1 (en) 2003-09-24 2005-09-08 James Dao Compositions of botanical extracts for treating malignancy-associated changes
WO2008127302A2 (en) * 2006-10-27 2008-10-23 Genyous BioMed International, Inc. Compositions for treatment and inhibition of pain
AU2011323155B2 (en) * 2010-11-04 2016-05-12 Genyous Biomed International Combination therapy for prostate cancer using botanical compositions and bicalutamide

Also Published As

Publication number Publication date
CN105636647A (zh) 2016-06-01
EP3003490B1 (en) 2019-11-13
EP3003490A1 (en) 2016-04-13
US20160143971A1 (en) 2016-05-26
JP2016523849A (ja) 2016-08-12
WO2014197519A1 (en) 2014-12-11
CA2951110A1 (en) 2014-12-11
EP3003490A4 (en) 2017-01-25

Similar Documents

Publication Publication Date Title
SG10201801433XA (en) Composition and vaccine for treating prostate cancer
IL273090B (en) Methods and preparations for the treatment of cancer
IL245281A0 (en) Methods and preparations for the treatment of cancer
IL245731A0 (en) Combined treatment for cancer
HK1209798A1 (en) Compositions and methods for treating cancer
EP2836482A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
EP2890720A4 (en) COMPOSITIONS AND METHODS OF TREATING CANCER
EP2968343A4 (en) POLY THERAPY FOR TREATING CANCER
EP3041470A4 (en) Methods and compositions for selective and targeted cancer therapy
GB201322725D0 (en) Cancer therapy
IL238177A0 (en) Methods and preparations for the treatment of cancer
HK1220900A1 (zh) 癌症的治療
SG11201507847UA (en) Cancer therapy
HK1216854A1 (zh) 用於治療癌症的組合物和方法
EP2961412A4 (en) CANCER THERAPY
SG11201510802QA (en) Combination therapy for prostate cancer using botanical compositions and docetaxel
SG11201510804UA (en) Novel formulations of botanical extracts for cancer therapy
HK1213475A1 (zh) 用於癌症治療的 、卡培他濱和奧沙利鉑的組合
EP2971044A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
EP2841102A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP2822593A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANCER
HK1214502A1 (zh) 用於癌症治療的 和卡培他濱的組合
GB201317213D0 (en) Cancer Therapy